GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer
- PMID: 14755684
- DOI: 10.1002/jcb.10740
GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer
Abstract
Somatic hypermethylation of CpG island sequences at GSTP1, the gene encoding the pi-class glutathione S-transferase, appears to be characteristic of human prostatic carcinogenesis. To consider the potential utility of this epigenetic alteration as a biomarker for prostate cancer, we present here a comprehensive review of the literature describing somatic GSTP1 changes in DNA from prostate cells and tissues. GSTP1 CpG island hypermethylation has been detected in prostate cancer DNA using a variety of assay techniques, including (i) Southern blot analysis (SB), after treatment with (5-m)C-sensitive restriction endonucleases, (ii) the polymerase chain reaction, following treatment with (5-m)C-sensitive restriction endonucleases (RE-PCR), (iii) bisulfite genomic sequencing (BGS), and (iv) bisulfite modification followed by the polymerase chain reaction, using primers selective for target sequences containing (5-m)C (MSP). In the majority of the case series so far reported, GSTP1 CpG island hypermethylation was present in DNA from at least 90% of prostate cancer cases. When analyses have been carefully conducted, GSTP1 CpG island hypermethylation has not been found in DNA from normal prostate tissues, or from benign prostatic hyperplasia (BPH) tissues, though GSTP1 CpG island hypermethylation changes have been detected in DNA from candidate prostate cancer precursor lesions proliferative inflammatory atrophy (PIA) and prostatic intraepithelial neoplasia (PIN). Using PCR methods, GSTP1 CpG island hypermethylation has also been detected in urine, ejaculate, and plasma from men with prostate cancer. GSTP1 CpG island hypermethylation, a somatic epigenetic alteration, appears poised to serve as a molecular biomarker useful for prostate cancer screening, detection, and diagnosis.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.Cancer Res. 2001 Dec 15;61(24):8611-6. Cancer Res. 2001. PMID: 11751372
-
Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.Clin Cancer Res. 2005 Jun 1;11(11):4037-43. doi: 10.1158/1078-0432.CCR-04-2446. Clin Cancer Res. 2005. PMID: 15930338
-
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):531-6. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9641498
-
Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.Eur Urol. 2004 Dec;46(6):698-708. doi: 10.1016/j.eururo.2004.07.022. Eur Urol. 2004. PMID: 15548435 Review.
-
Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.Pathology. 2007 Jun;39(3):299-304. doi: 10.1080/00313020701329906. Pathology. 2007. PMID: 17558856 Review.
Cited by
-
Firefighting, per- and polyfluoroalkyl substances, and DNA methylation of genes associated with prostate cancer risk.Environ Mol Mutagen. 2024 Jan-Feb;65(1-2):55-66. doi: 10.1002/em.22589. Epub 2024 Mar 24. Environ Mol Mutagen. 2024. PMID: 38523457
-
Targeting GSTP1 as Therapeutic Strategy against Lung Adenocarcinoma Stemness and Resistance to Tyrosine Kinase Inhibitors.Adv Sci (Weinh). 2023 Mar;10(7):e2205262. doi: 10.1002/advs.202205262. Epub 2023 Jan 29. Adv Sci (Weinh). 2023. PMID: 36709476 Free PMC article.
-
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol).Ther Adv Med Oncol. 2022 Apr 18;14:17588359221092486. doi: 10.1177/17588359221092486. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35465297 Free PMC article.
-
SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samples.Clin Epigenetics. 2022 Mar 10;14(1):37. doi: 10.1186/s13148-022-01252-4. Clin Epigenetics. 2022. PMID: 35272673 Free PMC article.
-
C. elegans protein interaction network analysis probes RNAi validated pro-longevity effect of nhr-6, a human homolog of tumor suppressor Nr4a1.Sci Rep. 2019 Oct 31;9(1):15711. doi: 10.1038/s41598-019-51649-0. Sci Rep. 2019. PMID: 31673088 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous